Quality of psychopharmacological medication use in nursing home residents

Research in Social & Administrative Pharmacy : RSAP
Linda Simoni-WastilaJudith A Lucas

Abstract

Despite well-documented evidence regarding antipsychotic use in older adults residing in nursing homes (NHs), there is a lack of evidence-based use and quality benchmarks for other psychopharmacological medications (PPMs), including antidepressants, anxiolytics, and sedative-hypnotics. To estimate the prevalence and patterns of use of PPMs and to measure the quality of PPM use. Using a 5% random sample of 2007 Medicare claims data linked to the Minimum Data Set 2.0, this cross-sectional study identified a nationally representative sample of 69,832 NH residents with ≥3 months of institutionalization. This study measured 1-year prevalence and quality of PPM use, as assessed by indication, dose, and duration of use defined and operationalized according to the current Centers for Medicare and Medicaid Services Unnecessary Medication Guidance for Surveyors and relevant practice guidelines. Over two-thirds of residents (72.1%, n=50,349) used ≥1 PPM in 2007, with the highest prevalence seen in antidepressants (59.4%), and the lowest in anxiolytics (8.9%). Almost two-thirds (61.0%) of PPM users used ≥2 PPM classes. Compared to other PPM therapeutic classes, antipsychotic users had greatest evidence of guideline adequate use by indicati...Continue Reading

References

Apr 1, 1990·Medical Care·G L Cafferata, S M Meyers
Feb 1, 1987·Nursing Management·P L Grimaldi
Jul 1, 1994·Journal of Gerontology·J N MorrisL A Lipsitz
Nov 30, 1999·BMJ : British Medical Journal·A Turrell, C M Castleden
Jan 5, 2000·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·J N MorrisS A Morris
Jul 24, 2002·Annales Françaises D'anesthèsie Et De Rèanimation·P Maurette, UNKNOWN Comité analyse et maîtrise du risque de la Sfar
Jun 27, 2003·The New England Journal of Medicine·Elizabeth A McGlynnEve A Kerr
Nov 7, 2003·The New England Journal of Medicine·Michael Spiegel, Christoph Pechlaner
Apr 26, 2005·The Journal of Legal Medicine·Jennifer L Hilliard
Jun 16, 2005·Archives of Internal Medicine·Becky A BriesacherBruce Stuart
Oct 20, 2005·JAMA : the Journal of the American Medical Association·Lon S SchneiderPhilip Insel
Dec 2, 2005·The New England Journal of Medicine·Philip S WangM Alan Brookhart
Jun 6, 2007·Annals of Internal Medicine·Sudeep S GillPaula A Rochon
Dec 12, 2007·BMC Health Services Research·Ilene H ZuckermanJose J Hernandez
May 28, 2008·Archives of Internal Medicine·Paula A RochonJerry H Gurwitz
Oct 28, 2008·Medical Care·Siran M KoroukianPatrick Murray
Dec 20, 2008·Journal of the American Geriatrics Society·Christopher M Perlman, John P Hirdes
Feb 7, 2009·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Joseph T HanlonStephanie A Studenski
Feb 12, 2009·Journal of the American Geriatrics Society·Rollin M WrightUNKNOWN Health, Aging and Body Composition Study
Dec 2, 2009·The American Journal of Geriatric Pharmacotherapy·Linda Simoni-WastilaAnand A Dalal
Jan 6, 2010·Health Affairs·H Stephen KayeMitchell P LaPlante
Jan 13, 2010·Archives of Internal Medicine·Yong ChenJerry H Gurwitz
Feb 4, 2010·Psychiatric Services : a Journal of the American Psychiatric Association·Pravin KambleRajender Aparasu
Jul 20, 2010·Research in Gerontological Nursing·Carlos H Rojas-FernandezCheryl A Sadowski
Dec 9, 2010·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Maha SaadEbtesam Ahmed
Feb 9, 2011·Archives of General Psychiatry·Helen C KalesFrederic C Blow
Mar 25, 2011·American Journal of Alzheimer's Disease and Other Dementias·Genevieve HenryRajesh R Tampi
May 14, 2011·The American Journal of Geriatric Pharmacotherapy·Swapna U KarkareRajender Aparasu
Jul 13, 2011·The Mount Sinai Journal of Medicine, New York·Erin K Kastenschmidt, Gary J Kennedy
Aug 10, 2011·Journal of the American Geriatrics Society·Joseph T HanlonMaurice W Dysken
Dec 24, 2011·The American Journal of Psychiatry·Helen C KalesFrederic C Blow
Feb 15, 2012·Journal of the American Geriatrics Society·Krista F HuybrechtsStephen Crystal
Jul 12, 2012·JAMA : the Journal of the American Medical Association·Mike Mitka
Dec 12, 2012·Health Services Research·Jennifer L Troyer, Wendy Sause
Mar 30, 2013·Clinical Journal of Oncology Nursing·Lori Johnson
Apr 4, 2013·The Annals of Pharmacotherapy·Rajender R AparasuHua Chen

❮ Previous
Next ❯

Citations

Jul 22, 2014·Journal of the American Geriatrics Society·Yu-Jung WeiJudith A Lucas
Jan 21, 2015·Health Services Research·John R BowblisChristopher S Brunt
Apr 23, 2015·Journal of the American Geriatrics Society·Kate L LapaneJennifer Tjia
May 12, 2016·Journal of the American Geriatrics Society·Linda Simoni-WastilaIlene Harris
May 3, 2018·Journal of the American Geriatrics Society·Mouna SawanSarah N Hilmer
Jun 22, 2017·BMC Health Services Research·Gunnar Tschudi BondevikEllen Catharina Tveter Deilkås
Aug 28, 2019·Journal of Clinical Medicine·Syed Shahzad HasanZaheer-Ud-Din Babar
Feb 10, 2021·Geriatric Nursing·Hege SolbergRose Mari Olsen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here